coronavirus vaccine being developed overseas.Dr. Mark Loeb, a professor at McMaster University, says the new DNA-based vaccine could be a part of Phase 2 testing in Canada sometime in the late fall or early 2021.“It’s a DNA vaccine that’s been produced by using computer modelling and artificial intelligence,” said Loeb. “We think it would be an effective vaccine to protect people from COVID-19.”Loeb says the vaccine was developed by a team at a U.K.
company called DIOSynVax founded by Canadian professor Jonathan Heeney, who studied at the University of Guelph.The new vaccine candidate – DIOS-CoVax2 – was developed using genetic sequences of all known coronaviruses, including those from bats that host many relatives of human coronaviruses.